|
MechanismL-type calcium channel blockers [+1] |
|
|
|
|
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.Hungary |
First Approval Date01 Feb 2011 |
/ CompletedNot Applicable Easypod Connect: A National, Multicentre, Observational Registry to Study Adherence and Long Term Outcomes of Therapy in Paediatric Subjects Using Easypod™ Electromechanical Device for Growth Hormone Treatment in Hungary
This is a Hungarian, Multicentre, Observational Study to study Adherence and Long Term Outcomes of Therapy in paediatric subjects using easypod™ electromechanical device for growth hormone treatment to assess the level of adherence of subject receiving SAIZEN® via easypod™.
/ CompletedNot Applicable An Observational Program to Evaluate Efficacy, Safety and Clinical Outcomes of Currently Used Pharmaceutical Therapies for Controlled Ovarian Stimulation (COS) in Assisted Reproductive Techniques (ART)
Human gonadotrophins have been successfully used for the treatment of infertility for more than 30 years. This observational study is being conducted to evaluate the efficacy and safety of the gonadotropins used for controlled ovarian stimulation (COS) in assisted reproductive technologies (ART).
100 Clinical Results associated with Merck Kft
0 Patents (Medical) associated with Merck Kft
100 Deals associated with Merck Kft
100 Translational Medicine associated with Merck Kft